That mad scramble for Pfizer vaccine

Ma. Ceres P. Doyo - @inquirerdotnet 05/27/2021

What did people’s mad scramble last week for the US-manufactured Pfizer vaccine tell us? But first, thank God it did not turn out to be a killer stampede reminiscent of TV’s live show “Wowowee” in 2006 that…

Why penalize us for choosing better vaccine?

Solita Collas-Monsod - @inquirerdotnet 05/22/2021

Just as I was about to write a column on amending the agri-agra law, or on election issues, or on PLDT inefficiency, the President, who in my book runs neck-and-neck with Ferdinand Marcos as the Philippines’ worst…

Duterte ‘sorry,’ returns Sinopharm jabs to China

Leila B. Salaverria, Maricar Cinco, Patricia Denise M. Chiu 05/07/2021

MANILA, Philippines — In a rare response to public criticism, President Rodrigo Duterte admitted it was wrong to get himself inoculated with the Sinopharm vaccine and ordered the return of the remainder of the 1,000 doses donated…

DOH drafting guidelines on mixed-use vaccination — FDA

Daphne Galvez - Reporter / @DYGalvezINQ 05/06/2021

MANILA, Philippines — The Department of Health (DOH) is already drafting guidelines to allow a person to receive different brands of coronavirus vaccine for first and second dose, an official of the Food and Drug Administration (FDA)…

Hubris, ineptness, and the vaccine program

Solita Callas-Monsod - @inquirerdotnet 02/27/2021

Food and Drug Administration (FDA) Director General Eric Domingo showed a lot of balls when he gave Sinovac’s CoronaVac the green light for emergency use authorization (EUA), but with a recommendation that it not be used for…

COVID-19 vaccines in the Philippine context

Gideon Lasco, Joshua San Pedro - @inquirerdotnet 12/16/2020

Several months and over 400,000 COVID-19 cases later, the Philippines has begun its long-awaited and promised process of acquiring vaccines as a means to end the pandemic. As early as April, President Duterte spoke optimistically of the…

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.